Clinical trial
Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing…
NCT00429442 · Anna Tsakiri, Other · Withdrawn
Key facts
| NCT number | NCT00429442 |
|---|---|
| Title | Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis |
| Official title | A Double Blind, Randomised, Placebo Controlled Study Investigating Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis in Patients Treated With Copaxone for at Least 3 Months |
| Lead sponsor | Anna Tsakiri, Other |
| Collaborators | Sanofi Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Relapsing Remitting Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Simvastatin, placebo |
| Enrollment | 0 |
| Start date | Mar 1, 2008 |
| Completion | Mar 1, 2011 |
| First posted | Jan 31, 2007 |
| Last update posted | Feb 20, 2014 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: